Capri EGM has funded and aquired a newly constructed lab and R&D facility for National Resilience Inc., a technology-focused biomanufacturing company decicated to broadening access to complex medicines and protecting biopharmaceutical supply chains against disruption.
Ology Bioservices, a wholly owned subsidiary of Resilience, and the operator of the Lab & Research facility, has recently been awarded contract valued as much as $250 million by the Department of Defense for manufacturing development of a monoclonal antibody as a medical countermeasure to botulinum neurotoxins. Resilience also has a multi-year agreement to produce mRNA for Moderna’s COVID-19 vaccine, a strategic multi-year R&D alliance with Harvard University to develop complex medicines, and a multi-product biomanufacturing development agreement with Takeda supporting their plasma-derived medicines portfolio.
The Resilience Lab & Research build-to-suit is located in North Florida’s Research and Life Science cluster near the University of Florida and the University of Florida’s Innovate Sid Martin Biotech Incubator, the No. 1 ranked biotech incubator globally. The property is surrounded by a variety of other symbiotic high-tech uses including bioscience and medical product development, pharma compounding, and R&D firms. The proximity to the University of Florida provides a pipeline of talent and research opportunities.
Capri EGM confirms that life science and R&D corporate real estate remain high conviction themes for its ongoing build-to-suit program and investment activity and believes that these types of assets are among the biggest beneficiaries of the developing macroeconomic trends. Life science real estate capital markets set a record in 2021, with investment volumes of $18.4 billion, according to Newmark. Capri EGM believes the pandemic has only increased the need for these types of assets. As Capri EGM looks to current investment, innovation-oriented markets with leading research universities will remain areas of focus for its investment activity as it believes these markets will continue to experience strong demand from corporations interested in participating in their local ecosystems.
